Steve Booyens

Steve Booyens

About Steve Booyens

Steve co-founded Pearl Gray Equity and Research in 2020 and has been responsible for institutional equity research and PR ever since. Before founding the firm, Steve spent time working in various finance roles in London and South Africa. He holds an MSc in Investment Banking from Queen Mary – University of London and is working towards his Ph.D. in Finance, in which he’s attempting to challenge the renowned Fama-French 5-factor pricing model by incorporating ESG factors.

His articles are published on various reputable web pages such as Seeking Alpha, TipRanks, Yahoo Finance, and Benzinga. Steve’s articles on InvestorPlace form an interesting juxtaposition between mainstream opinion and objective theory. Readers can expect coverage on frequently traded stocks, cryptocurrencies, crowdfunding, and ETFs.

Recent Articles

5 Dividend Stocks to Buy For Yield-Hungry, Risk Tolerant Investors

High-yielding dividend stocks to buy are the go-to now. However, yields aren't always sustainable and the selection process is critical.

ARK Innovation Probably Won’t Recover

The ARK Innovation ETF isn't in great shape. This shouldn't be a surprise to investors, as the fund isn't backed by solid fundamentals.

Top 5 Oversold Chinese Stocks to Buy Before They Rebound

Despite Wall Street's hesitancy, there are still some great Chinese stocks to buy. Key metrics suggest that they're undervalued and worth it.

The Top 5 Dow Stocks to Buy Now

A few high-quality Dow stocks haven't been picked up yet, presenting lucrative buying opportunities for optimists.

Ginkgo Bioworks’ Animal-Free Eggs Make DNA Stock Enticing

Ginkgo's animal-free eggs deal with Evo food could be just what its overlooked stock needed to reach its full potential. DNA stock is a buy.